Allworth Financial’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25K | Buy |
240
+206
| +606% | +$1.93K | ﹤0.01% | 3643 |
|
|
2025
Q1 | $453 | Sell |
34
-125
| -79% | -$1.67K | ﹤0.01% | 3699 |
|
|
2024
Q4 | $2.23K | Sell |
159
-195
| -55% | -$2.73K | ﹤0.01% | 3110 |
|
|
2024
Q3 | $6.82K | Hold |
354
| – | – | ﹤0.01% | 2431 |
|
|
2024
Q2 | $8.17K | Hold |
354
| – | – | ﹤0.01% | 2311 |
|
|
2024
Q1 | $8.43K | Sell |
354
-10
| -3% | -$238 | ﹤0.01% | 2177 |
|
|
2023
Q4 | $7.87K | Buy |
364
+355
| +3,944% | +$7.67K | ﹤0.01% | 2083 |
|
|
2023
Q3 | $131 | Sell |
9
-18
| -67% | -$262 | ﹤0.01% | 3295 |
|
|
2023
Q2 | $566 | Hold |
27
| – | – | ﹤0.01% | 2872 |
|
|
2023
Q1 | $571 | Sell |
27
-39
| -59% | -$825 | ﹤0.01% | 2818 |
|
|
2022
Q4 | $1.68K | Buy |
66
+31
| +89% | +$789 | ﹤0.01% | 2302 |
|
|
2022
Q3 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 2497 |
|